Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases-Reference-Cited by-同舟云学术

Discovery of NLRP3 inhibitors using machine learning: Identification of a hit compound to treat NLRP3 activation-driven diseases

Published:2023-11 Issue: Volume:260 Page:115784
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Shi Cheng,Zhang Xiangyu,Chi Xiaowei,Zhou Yi Ran,Lyu Weiping,Gao Tongfei,Zhou Jiaxu,Chen Yanming,Yi Chuxiao,Sun Xiaojiao,Zhang Liangren,Liu Zhenming^ORCID

Funder

National Natural Science Foundation of China

Beijing Natural Science Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference43 articles.

1. Inhibition of the NLRP3 inflammasome activation/assembly through the activation of the PI3K pathway by naloxone protects neural stem cells from ischemic condition;Kim;Mol. Neurobiol.,2023

2. Role of innate immune system in systemic sclerosis;Fullard;Semin. Immunopathol.,2015

3. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome;Sharif;Nature,2019

4. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway;Wang;Nat. Immunol.,2014

5. Cryopyrin activates the inflammasome in response to toxins and ATP;Mariathasan;Nature,2006

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Potent, Specific, and Orally Available NLRP3 Inflammasome Inhibitors Based on Pyridazine Scaffolds for the Treatment of Septic Shock and Peritonitis;Journal of Medicinal Chemistry;2024-08-22